Prescription Required
Inclusive of all taxes
In Nausea Satron Plus 2 mg/125 mg Suspension blocks the action of chemicals in the body that can make you feel or be sick. It is often used to prevent nausea and vomiting that may be caused due to some medicines or cancer treatment. This medicine helps you recover more comfortably from cancer treatments such as radiation therapy or chemotherapy. It is also effective at preventing nausea and vomiting after an operation (in adults only). The dose will depend on what you are being treated for but always take this medicine as it is prescribed.
It is unsafe to consume alcohol with Satron Plus 2 mg/125 mg Suspension.
Satron Plus 2 mg/125 mg Suspension is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Satron Plus 2 mg/125 mg Suspension is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Satron Plus 2 mg/125 mg Suspension does not usually affect your ability to drive.
Satron Plus 2 mg/125 mg Suspension should be used with caution in patients with severe kidney disease. Dose adjustment of Satron Plus 2 mg/125 mg Suspension may be needed. Please consult your doctor. However, Satron Plus 2 mg/125 mg Suspension contains paracetamol which is considered the safest painkiller for kidney disease patients.
Satron Plus 2 mg/125 mg Suspension should be used with caution in patients with liver disease. Dose adjustment of Satron Plus 2 mg/125 mg Suspension may be needed. Please consult your doctor. However, the use of Satron Plus 2 mg/125 mg Suspension is not recommended in patients with severe liver disease and active liver disease.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More